WallStreetZenWallStreetZen

NASDAQ: CDMO
Avid Bioservices Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CDMO

Based on 2 analysts offering 12 month price targets for Avid Bioservices Inc

Min Forecast
$12.00-2.36%
Avg Forecast
$12.25-0.33%
Max Forecast
$12.50+1.71%

Should I buy or sell CDMO stock?

Based on 2 analysts offering ratings for Avid Bioservices Inc.

Buy
Strong Buy
1 analysts 50%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CDMO stock forecasts and price targets.

CDMO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-11-07
lockedlocked$00.00+00.00%2024-09-10

1 of 1

Forecast return on equity

Is CDMO forecast to generate an efficient return?

Company
-22.3%
Industry
13,276.57%
Market
301.04%
CDMO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CDMO forecast to generate an efficient return on assets?

Company
-3.91%
Industry
5,419.81%
CDMO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CDMO earnings per share forecast

What is CDMO's earnings per share in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.38
Avg 2 year Forecast
-$0.21

CDMO revenue forecast

What is CDMO's revenue in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
$164.0M+15.2%
Avg 2 year Forecast
$191.1M+34.24%
CDMO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDMO revenue growth forecast

How is CDMO forecast to perform vs Biotechnology companies and vs the US market?

Company
15.86%
Industry
53.11%
Market
7.5%
CDMO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDMO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDMO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CDMO$12.29$12.25-0.33%Buy
CRGX$17.11$31.67+85.08%Strong Buy
AUTL$2.92$10.20+249.32%Strong Buy
IMTX$7.68$17.00+121.35%Strong Buy
IMNM$12.70$28.00+120.47%Strong Buy
View Top Biotech Stocks

Avid Bioservices Stock Forecast FAQ

Is Avid Bioservices Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CDMO) stock is to Buy CDMO stock.

Out of 2 analysts, 1 (50%) are recommending CDMO as a Strong Buy, 0 (0%) are recommending CDMO as a Buy, 1 (50%) are recommending CDMO as a Hold, 0 (0%) are recommending CDMO as a Sell, and 0 (0%) are recommending CDMO as a Strong Sell.

If you're new to stock investing, here's how to buy Avid Bioservices stock.

What is CDMO's earnings growth forecast for 2025-2026?

(NASDAQ: CDMO) Avid Bioservices's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.49%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.11%.

Avid Bioservices's earnings in 2024 is -$144,165,000.On average, 2 Wall Street analysts forecast CDMO's earnings for 2025 to be -$24,242,141, with the lowest CDMO earnings forecast at -$26,793,945, and the highest CDMO earnings forecast at -$21,690,337.

In 2026, CDMO is forecast to generate -$13,077,997 in earnings, with the lowest earnings forecast at -$14,672,875 and the highest earnings forecast at -$11,483,119.

What is CDMO's revenue growth forecast for 2025-2026?

(NASDAQ: CDMO) Avid Bioservices's forecast annual revenue growth rate of 15.86% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 53.11%, and while it is forecast to beat the US market's average forecast revenue growth rate of 7.5%.

Avid Bioservices's revenue in 2024 is $142,358,000.On average, 1 Wall Street analysts forecast CDMO's revenue for 2025 to be $10,462,397,712, with the lowest CDMO revenue forecast at $10,462,397,712, and the highest CDMO revenue forecast at $10,462,397,712.

In 2026, CDMO is forecast to generate $12,191,245,139 in revenue, with the lowest revenue forecast at $12,191,245,139 and the highest revenue forecast at $12,191,245,139.

What is CDMO's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: CDMO) forecast ROA is -3.91%, which is lower than the forecast US Biotechnology industry average of 5,419.81%.

What is CDMO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CDMO price target, the average CDMO price target is $12.25, with the highest CDMO stock price forecast at $12.50 and the lowest CDMO stock price forecast at $12.00.

On average, Wall Street analysts predict that Avid Bioservices's share price could fall to $12.25 by Nov 7, 2025. The average Avid Bioservices stock price prediction forecasts a potential downside of 0.33% from the current CDMO share price of $12.29.

What is CDMO's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: CDMO) Avid Bioservices's current Earnings Per Share (EPS) is -$2.28. On average, analysts forecast that CDMO's EPS will be -$0.38 for 2025, with the lowest EPS forecast at -$0.42, and the highest EPS forecast at -$0.34. In 2026, CDMO's EPS is forecast to hit -$0.21 (min: -$0.23, max: -$0.18).

What is CDMO's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: CDMO) forecast ROE is -22.3%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.